Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH/MASH”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06215716
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Who this might be right for
NASH With FibrosisMASH With Fibrosis
Akero Therapeutics, Inc 1,650
Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168
Not applicableStudy completedNCT06688149
What this trial is testing

NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 536
Not applicableLooking for participantsNCT07632677
What this trial is testing

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated SteatohepatitisMetabolic Dysfunction-associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 10,000
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Testing effectiveness (Phase 2)Study completedNCT03938246
What this trial is testing

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Sagimet Biosciences Inc. 142
Testing effectiveness (Phase 2)Study completedNCT04929483
What this trial is testing

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT06108219
What this trial is testing

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-associated Steatohepatitis (MASH)
Corcept Therapeutics 175
Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Large-scale testing (Phase 3)Looking for participantsNCT06632444
What this trial is testing

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim 1,800
Not applicableStudy completedNCT05765890
What this trial is testing

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

Who this might be right for
Non-alcoholic Steatohepatitis (MASH)Non-alcoholic Fatty Liver Disease (MASLD)
Novo Nordisk A/S 675
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisNon-alcoholic Fatty Liver Disease
GlaxoSmithKline 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Not applicableUnknownNCT06676813
What this trial is testing

Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 72
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Early research (Phase 1)Active Not RecruitingNCT06947304
What this trial is testing

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics 9
Not applicableNot Yet RecruitingNCT06764056
What this trial is testing

Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated-dysfunction Steatohepatitis (MASH)Obesity
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 120
Next Page